In the Indian pharmaceutical industry, there were 5 private equity deals announced in Q3 2023, worth a total value of $281m, according to GlobalData’s Deals Database. The $155m investment by International Finance and Quadria Capital Investment Management in Maxivision Eye Hospitals was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes and the Private Equity deal activity are included in GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, private equity deal activity in India decreased by 91% in Q3 2023 compared with the previous quarter’s total of $3.2bn and rose by 462% as compared to Q3 2022. Related deal volume decreased by 29% in Q3 2023 versus the previous quarter and was 25% higher than in Q3 2022.
The top-ranked financial advisors supporting these private equity deals in India in Q3 2023 were BDA Partners; Lazard; Nine Rivers Capital Holdings with 1, 1, 1 deals respectively.
The top-ranked legal advisorss supporting these private equity deals in India Q3 2023 were AZB & Partners; Khaitan & Co; Acuity Capital Advisors Pvt. with 3, 2, 1 deals respectively.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q3 2023 – Thematic Intelligence, buy the report here.